Furthermore, the study of the cellular origin and molecular pathogenesis of CLL would benefit from a better understanding of the diversity of clonal B cells and the role of any CD5low subpopulation [4] given that studies normally focus on the CD5+/high B-cell populations [13]. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.